[1]
|
Beeri, M.S., Ravona-Springer, R., Silverman, J.M. and Haroutunian, V. (2009) The effects of cardiovascular risk factors on cognitive compromise. Dialogues in Clinical Neuroscience, 11, 201-212.
|
[2]
|
Middleton, L.E., Barnes, D.E., Lui, L.Y. and Yaffe, K. (2010) Physical activity over the life course and its association with cognitive performance and impairment in old age. Journal of the American Geriatrics Society, 58, 1322-1326. doi:10.1111/j.1532-5415.2010.02903.x
|
[3]
|
Yaffe, K., Vittinghoff, E., Lindquist, K., et al. (2010) Posttraumatic stress disorder and risk of dementia among us veterans. Archives of General Psychiatry, 67, 608-613. doi:10.1001/archgenpsychiatry.2010.61
|
[4]
|
Tzourio, C., Dufouil, C., Ducimetiere, P. and Alperovitch, A. (1999) Cognitive decline in individuals with high blood pressure: A longitudinal study in the elderly. Eva study group. Epidemiology of vascular aging. Neurology, 53, 1948-1952.
|
[5]
|
Mielke, M. M., Rosenberg, P. B., Tschanz, J., et al. (2007) Vascular factors predict rate of progression in alzheimer disease. Neurology, 69, 1850-1858.
doi:10.1212/01.wnl.0000279520.59792.fe
|
[6]
|
Solomon, A., Kareholt, I., Ngandu, T., et al. (2007) Serum cholesterol changes after midlife and late-life cognition: Twenty-one-year follow-up study. Neurology, 68, 751-756.
doi:10.1212/01.wnl.0000256368.57375.b7
|
[7]
|
Yaffe, K., Barrett-Connor, E., Lin, F. and Grady, D. (2002) Serum lipoprotein levels, statin use, and cognitive function in older women. Archives of Neurology, 59, 378-384.
doi:10.1001/archneur.59.3.378
|
[8]
|
Reitz, C., Luchsinger, J., Tang, M.X., Manly, J. and Mayeux, R. (2005) Impact of plasma lipids and time on memory performance in healthy elderly without dementia. Neurology, 64, 1378-1383.
doi:10.1212/01.WNL.0000158274.31318.3C
|
[9]
|
Whitmer, R. A., Sidney, S., Selby, J., Johnston, S. C. and Yaffe, K. (2005) Midlife cardiovascular risk factors and risk of dementia in late life. Neurology, 64, 277-281.
doi:10.1212/01.WNL.0000149519.47454.F2
|
[10]
|
Schnaider Beeri, M., Goldbourt, U., Silverman, J.M., et al. (2004) Diabetes mellitus in midlife and the risk of dementia three decades later. Neurology, 63, 1902-1907.
|
[11]
|
Yaffe, K., Kanaya, A., Lindquist, K., et al. (2004) The metabolic syndrome, inflammation, and risk of cognitive decline. Journal of the American Medical Association, 292, 2237-2242. doi:10.1001/jama.292.18.2237
|
[12]
|
Pfeiffer, E. (1975) A short portable mental status questionnaire for the assessment of organic brain deficit in elderly patients. Journal of the American Geriatrics Society, 23, 433-441.
|
[13]
|
Folstein, M.F., Folstein, S.E. and McHugh, P.R. (1975) “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research, 12, 189-198.
doi:10.1016/0022-3956(75)90026-6
|
[14]
|
Nasreddine, Z.S., Phillips, N. A., Bedirian, V., et al. (2005) The montreal cognitive assessment, moca: A brief screening tool for mild cognitive impairment. Journal of the American Geriatrics Society, 53, 695-699.
doi:10.1111/j.1532-5415.2005.53221.x
|
[15]
|
Smith, T., Gildeh, N. and Holmes, C. (2007) The montreal cognitive assessment: Validity and utility in a memory clinic setting. Canadian Journal of Psychiatry, 52, 329-332.
|
[16]
|
Hoops, S., Nazem, S., Siderowf, A. D., et al. (2009) Validity of the MoCA and mmse in the detection of mci and dementia in parkinson disease. Neurology, 73, 1738-1745. doi:10.1212/WNL.0b013e3181c34b47
|
[17]
|
D'Agostino, R. B., Sr., Grundy, S., Sullivan, L. M. and Wilson, P. (2001) Validation of the framingham coronary heart disease prediction scores: Results of a multiple ethnic groups investigation. Journal of the American Medical Association, 286, 180-187. doi:10.1001/jama.286.2.180
|
[18]
|
D’Agostino, R.B., Wolf, P.A., Belanger, A.J. and Kannel, W.B. (1994) Stroke risk profile: Adjustment for antihypertensive medication. The framingham study. Stroke, 25, 40-43. doi:10.1161/01.STR.25.1.40
|
[19]
|
Victor, R. G., Haley, R. W., Willett, D. L., et al. (2004) The dallas heart study: A population-based probability sample for the multidisciplinary study of ethnic differences in cardiovascular health. American Journal of Cardiology, 93, 1473-1480.
|
[20]
|
Wilson, P.W., D’Agostino, R.B., Levy, D., et al. (1998) Prediction of coronary heart disease using risk factor categories. Circulation, 97, 1837-1847.
|
[21]
|
Aggarwal, A. and Kean, E. (2010) Comparison of the folstein mini mental state examination (mmse) to the montreal cognitive assessment (MoCA) as a cognitive screening tool in an inpatient rehabilitation setting. Neuroscience and Medicine, 1, 39-42.
doi:10.4236/nm.2010.12006
|
[22]
|
Bernstein, I.H., Lacritz, L., Barlow, C.E., Weiner, M.F. and Defina, L. F. (2011) Psychometric evaluation of the montreal cognitive assessment (MoCA) in three diverse samples. Clinical Neuropsychology, 25, 119-126.
doi:10.1080/13854046.2010.533196
|
[23]
|
McLennan, S.N., Mathias, J.L., Brennan, L.C. and Stewart, S. (2010) Validity of the montreal cognitive assessment (MoCA) as a screening test for mild cognitive impairment (MCI) in a cardiovascular population. Journal of Geriatric Psychiatry and Neurology, 24, 33-38.
|
[24]
|
Kuczynski, B., Jagust, W., Chui, H.C. and Reed, B. (2009) An inverse association of cardiovascular risk and frontal lobe glucose metabolism. Neurology, 72, 738-743.
doi:10.1212/01.wnl.0000343005.35498.e5
|
[25]
|
Zade, D., Beiser, A., McGlinchey, R., et al. (2010) Interactive effects of apolipoprotein E type 4 genotype and cerebrovascular risk on neuropsychological performance and structural brain changes. Journal of Stroke and Cerebrovascular Diseases, 19, 261-268.
doi:10.1016/j.jstrokecerebrovasdis.2009.05.001
|
[26]
|
Fillenbaum, G.G., Landerman, L.R., Blazer, D.G., et al. (2001) The relationship of APOE genotype to cognitive functioning in older African-American and caucasian community residents. Journal of the American Geriatrics Society, 49, 1148-1155.
doi:10.1212/01.WNL.0000149643.91367.8A
|
[27]
|
Blair, C.K., Folsom, A.R., Knopman, D.S., et al. (2005) APOE genotype and cognitive decline in a middle-aged cohort. Neurology, 64, 268-276.
doi:10.1212/01.WNL.0000149643.91367.8A
|
[28]
|
Wisdom, N.M., Callahan, J.L. and Hawkins, K.A. (2011) The effects of apolipoprotein e on non-impaired cognitive functioning: A meta-analysis. Neurobiology of Aging, 32, 63-74. doi:10.1001/jama.282.1.40
|
[29]
|
Haan, M.N., Shemanski, L., Jagust, W.J., Manolio, T.A. and Kuller, L. (1999) The role of APOE epsilon4 in modulating effects of other risk factors for cognitive decline in elderly persons. Journal of the American Medical Association, 282, 40-46. doi:10.1001/jama.282.1.40
|
[30]
|
Qiu, C. and Fratiglioni, L. (2010) Apolipoprotein E epsilon4 status and cognitive decline with and without dementia. Archives of Neurology, 67, 1036.
doi:10.1001/archneurol.2010.163
|
[31]
|
Kozauer, N.A., Mielke, M.M., Chan, G.K., Rebok, G.W. and Lyketsos, C.G. (2008) Apolipoprotein e genotype and lifetime cognitive decline. International Psychogeriatrics, 20, 109-123. doi:10.1017/S104161020700587X
|